Tag: Truvada

HIV advocate Cathy Murombedzi upbeat about HIV cure

Kuda Pembere

A bullish veteran journalist and Health Communicators Forum (HCF) vice chairperson Catherine Murombedzi is among the hopefuls who live to tell this tale. By Kudakwashe Pembere Seeing her feels like reliving the biblical times when Jews waited for the Messiah. Having kept her faith, Cathy is upbeat she will see the HIV cure in her lifetime. I am certain an HIV Cure is possible. There was no treatment at the onset of HIV in the early 1980s up to the 90s, but here we are today, there is anti-retroviral therapy,…

Read More

PrEP Use High Among Young African Girls But Fades After Three Months- Study

Healthtimes

IN a study of open-label Truvada as daily pre-exposure prophylaxis (PrEP) to prevent HIV among 427 young African women and adolescent girls, 95% initiated the HIV prevention strategy, and most used PrEP for the first three months. However, PrEP use fell among participants in this critical population during a year of follow-up clinic visits, although HIV incidence at 12 months was low. The preliminary results suggest that tailored, evidence-based adherence support strategies may be needed to durably engage young African women in consistent PrEP use. The study, known as HPTN…

Read More

11 800 Zimbabweans On PrEP

Healthtimes

OVER 11 800 Zimbabweans have been initiated on Pre-Exposure Prophylaxis as of last month, an AVAC fellow said on Monday. By Kudakwashe Pembere Addressing an International AIDS Society Harare Scientific Symposium, AVAC Fellow-cum-Pangaea Aids Zimbabwe Trust coordinator Definate Nhamo said the number was huge. “As of May 2019, we have about 11 800 who have been initiated on on PrEP,” she said. Following the youths demand of PrEP, she said PrEP was only distributed to certain populations perceived to be at risk of contracting HIV. “So in Zimbabwe we started…

Read More

Over 8 000 Zimbabweans on PrEP

Healthtimes

ZIMBABWE has to date managed to initiate over 8 000 people on Pre-Exposure Prophylaxis  (PrEP) since commencement of the project in 2016, a government official said on Thursday.   By Kudakwashe Pembere Currently administered in the form of tablets, PrEP has been studied to be effective in the protection of HIV negative people against the disease. Since adoption of PrEP as a preventive measure against STIs in Zimbabwe in 2016, about 8 482 people have been initiated. Ministry of Health and Childcare National HIV Prevention Coordinator Ms Getrude Ncube told…

Read More